Prof. Falasca did his graduate and postgraduate studies in Italy. He held a postdoctoral researcher position at the New York University Medical Center. In 2001 he moved to London where he was appointed as Senior Lecturer (University College London). In 2007 he was appointed as Professor of Molecular Pharmacology (Queen Mary University of London). He is currently Professor of Metabolism at Curtin University, Perth, Australia. He has made seminal and significant contributions on the biological activity and signalling properties of bioactive lipids. His research group iis currently focusing primarily on the identification of novel therapeutic strategies for pancreatic cancer.